Home » Topics » BioWorld Science

BioWorld Science
RSS

New beclomethasone formulation cleared for marketing

July 5, 1996

Cephalon reveals multicatalytic protease inhibitors

July 5, 1996

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Servier's prolyl endopeptidase inhibitor effective in amnesia model

July 5, 1996

Anseculin HCl enters phase II clinical trials

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Dolasetron equiefficent to granisetron in chemotherapy-induced emesis

July 5, 1996

Regeneron, Medtronic to collaborate on Axokine delivery system

July 5, 1996

Medeva shareholders OK Rochester take-over

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...